{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T21:11:13Z","timestamp":1785532273318,"version":"3.56.0"},"reference-count":50,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2010.0677","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T05:19:15Z","timestamp":1525238355000},"source":"Crossref","is-referenced-by-count":5,"title":["New Developments in the Diagnosis of Dementia"],"prefix":"10.3238","author":[{"given":"Gerhard W.","family":"Eschweiler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Leyhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kl\u00f6ppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"H\u00fcll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2010,10,1]]},"reference":[{"key":"10.3238\/arztebl.2010.0677_ref1","unstructured":". Yearbook 2006. Alzheimer Europe 2006."},{"key":"10.3238\/arztebl.2010.0677_ref2","unstructured":"Alzheimer A: \u00dcber eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift f\u00fcr Psychiatrie 1907; 64: 146\u20138."},{"key":"10.3238\/arztebl.2010.0677_ref3","doi-asserted-by":"crossref","unstructured":"Schlachetzki JCM, H\u00fcll M: Microglial activation in Alzheimer\u2019s disease. Current Alzheimer Research 2009; 6: 554\u201363.","DOI":"10.2174\/156720509790147179"},{"key":"10.3238\/arztebl.2010.0677_ref4","doi-asserted-by":"crossref","unstructured":"Braak H, Braak E: Staging of Alzheimer's disease-related neuro-fibrillary changes. Neurobiol Aging 1995; 16(3): 271\u20138.","DOI":"10.1016\/0197-4580(95)00021-6"},{"key":"10.3238\/arztebl.2010.0677_ref5","doi-asserted-by":"crossref","unstructured":"Petersen RC: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 183\u201394.","DOI":"10.1111\/j.1365-2796.2004.01388.x"},{"key":"10.3238\/arztebl.2010.0677_ref6","doi-asserted-by":"crossref","unstructured":"Metternich B, Schmidtke K, H\u00fcll M: How are memory complaints in functional memory disorder related to measures of affect, metamemory and cognition? Journal of Psychosomatic Research 2009; 66: 435\u201344.","DOI":"10.1016\/j.jpsychores.2008.07.005"},{"key":"10.3238\/arztebl.2010.0677_ref7","doi-asserted-by":"crossref","unstructured":"Jessen F, Wiese B, Cvetanovska G, et al.: Patterns of subjective memory impairment in the elderly: association with memory performance. Psychol Med 2007; 37(12): 1753\u201362.","DOI":"10.1017\/S0033291707001122"},{"key":"10.3238\/arztebl.2010.0677_ref8","doi-asserted-by":"crossref","unstructured":"Petersen RC, Negash S: Mild cognitive impairment: an overview. CNS Spectr 2008; 13(1): 45\u201353.","DOI":"10.1017\/S1092852900016151"},{"key":"10.3238\/arztebl.2010.0677_ref9","doi-asserted-by":"crossref","unstructured":"Schmidtke K, Hermeneit S: High rate of conversion to Alzheimer's disease in a cohort of amnestic MCI patients. Int Psychogeriatr 2008; 20(1): 96\u2013108.","DOI":"10.1017\/S1041610207005509"},{"key":"10.3238\/arztebl.2010.0677_ref10","doi-asserted-by":"crossref","unstructured":"Luck T, Riedel-Heller SG, Kaduszkiewicz H et al.: AgeCoDe group: Mild cognitive impairment in general practice: age-specific prevalence and correlate results from the German study on ageing, cognition and dementia in primary care patients (AgeCoDe). Dement Geriatr Cogn Disord 2007; 24(4): 307\u201316.","DOI":"10.1159\/000108099"},{"key":"10.3238\/arztebl.2010.0677_ref11","unstructured":"Finckh U: Genetische Faktoren bei Alzheimer-Demenz. Dtsch Arztebl 2006; 103(15): A 1010\u20136."},{"key":"10.3238\/arztebl.2010.0677_ref12","unstructured":"Mahlberg R, Gutzmann H: Zertifizierte medizinische Fortbildung: Diagnostik von Demenzerkrankungen. Dtsch Arztebl 2005; 102(28\u201329): A 2032\u20139."},{"key":"10.3238\/arztebl.2010.0677_ref13","doi-asserted-by":"crossref","unstructured":"Mitchell AJ: A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. J Psychiatr Res 2009; 43(4): 411\u201331.","DOI":"10.1016\/j.jpsychires.2008.04.014"},{"key":"10.3238\/arztebl.2010.0677_ref14","doi-asserted-by":"crossref","unstructured":"Scheurich A, M\u00fcller MJ, Siessmeier T, Bartenstein P, Schmidt LG, Fellgiebel A: Validating the DemTect with 18-fluoro-2-deoxy-glucose positron emission tomography as a sensitive neuropsychological screening test for early Alzheimer disease in patients of a memory clinic. Dement Geriatr Cogn Disord 2005; 20(5): 271\u20137.","DOI":"10.1159\/000088248"},{"key":"10.3238\/arztebl.2010.0677_ref15","doi-asserted-by":"crossref","unstructured":"Leyhe T, Milian M, M\u00fcller S, Eschweiler GW, Saur R: The minute hand phenomenon in the Clock Test of patients with early Alzheimer\u2019s disease. J Geriatr Psychiatry Neurol 2009; 22: 119\u201329.","DOI":"10.1177\/0891988709332941"},{"key":"10.3238\/arztebl.2010.0677_ref16","doi-asserted-by":"crossref","unstructured":"Peters JM, Hummel T, Kratzsch T, Lotsch J, Skarke C, Fr\u00f6lich L: Olfactory function in mild cognitive impairment and Alzheimer's disease: an investigation using psychophysical and electrophysiological techniques. Am J Psychiatry 2003; 160(11): 1995\u20132002.","DOI":"10.1176\/appi.ajp.160.11.1995"},{"key":"10.3238\/arztebl.2010.0677_ref17","doi-asserted-by":"crossref","unstructured":"Tabert MH, Liu X, Doty RL, et al.: A 10-item smell identification scale related to risk for Alzheimer's disease. Ann Neurol 2005; 58(1): 155\u201360.","DOI":"10.1002\/ana.20533"},{"key":"10.3238\/arztebl.2010.0677_ref18","doi-asserted-by":"crossref","unstructured":"Ownby RL, Crocco E, Acevedo A, John J, Loewenstein D: Depression and Risk for Alzheimer Disease: Systematic Review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 2006; 63: 530\u20138.","DOI":"10.1001\/archpsyc.63.5.530"},{"key":"10.3238\/arztebl.2010.0677_ref19","doi-asserted-by":"crossref","unstructured":"Kl\u00f6ppel S, Stonnington CM, Barnes J, et al.: Accuracy of dementia diagnosis: a direct comparison between radiologists and a computerized method. Brain 2008: 131(11): 2969\u201374.","DOI":"10.1093\/brain\/awn239"},{"key":"10.3238\/arztebl.2010.0677_ref20","doi-asserted-by":"crossref","unstructured":"Kl\u00f6ppel S, Stonnington CM, Chu C, et al.: Automatic classification of MR scans in Alzheimer's disease. Brain 2008; 131(3): 681\u20139.","DOI":"10.1093\/brain\/awm319"},{"key":"10.3238\/arztebl.2010.0677_ref21","doi-asserted-by":"crossref","unstructured":"Teipel SJ, Born C, Ewers M, et al.: Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment. Neuroimage 2007; 38(1): 13\u201324.","DOI":"10.1016\/j.neuroimage.2007.07.008"},{"key":"10.3238\/arztebl.2010.0677_ref22","doi-asserted-by":"crossref","unstructured":"Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L: Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 2006; 5: 228\u201334.","DOI":"10.1016\/S1474-4422(06)70355-6"},{"key":"10.3238\/arztebl.2010.0677_ref23","doi-asserted-by":"crossref","unstructured":"Vemuri P, Wiste HJ, Weigand SD, et al.: MRI and CSF biomarkers in normal, MCI, and AD subjects: Predicting future clinical change. Neurology 2009; 73: 294\u2013301.","DOI":"10.1212\/WNL.0b013e3181af79fb"},{"key":"10.3238\/arztebl.2010.0677_ref24","doi-asserted-by":"crossref","unstructured":"Dubios B, Feldman HH, Jacova C, et al.: Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734\u201346.","DOI":"10.1016\/S1474-4422(07)70178-3"},{"key":"10.3238\/arztebl.2010.0677_ref25","doi-asserted-by":"crossref","unstructured":"Ellison JM: A 60-year-old woman with mild memory impairment: review of mild cognitive impairment. JAMA 2008; 300(13): 1566\u201374.","DOI":"10.1001\/jama.300.9.jrr80008"},{"key":"10.3238\/arztebl.2010.0677_ref26","unstructured":". The Alzheimer Europe Magazine Issue 3, May 2009 page 14."},{"key":"10.3238\/arztebl.2010.0677_ref27","unstructured":", Diagnostik degenerativer Demenzen (Morbus Alzheimer,frontotemporale Demenz, Lewy-K\u00f6rperchen-Demenz)"},{"key":"10.3238\/arztebl.2010.0677_ref28","unstructured":""},{"key":"10.3238\/arztebl.2010.0677_ref29","unstructured":"2008 Leitlinie der DEGAM (shortened version)"},{"key":"10.3238\/arztebl.2010.0677_ref30","doi-asserted-by":"crossref","unstructured":"Wilson RS, Arnold SE, Schneider JA, Tang Y, Bennett DA: The relationship between cerebral Alzheimer\u00b4s disease and odour identification in old age. J Neurol Neurosurg Psychiatry 2007; 78(1): 30\u20135.","DOI":"10.1136\/jnnp.2006.099721"},{"key":"10.3238\/arztebl.2010.0677_ref31","doi-asserted-by":"crossref","unstructured":"Abdulrab K, Heun R : Subjective Memory Impairment. A review of its definitions indicates the need for a comprehensive set of standardised and validated criteria. Eur Psychiatry 2008; 23(5): 321\u201330.","DOI":"10.1016\/j.eurpsy.2008.02.004"},{"key":"10.3238\/arztebl.2010.0677_ref32","doi-asserted-by":"crossref","unstructured":"Visser PJ, Kester A, Jolles J, et al. Ten-year risk of dementia in subjects with mild cognitive impairment. Neurology 2006; 67: 1201\u20137.","DOI":"10.1212\/01.wnl.0000238517.59286.c5"},{"key":"10.3238\/arztebl.2010.0677_ref33","doi-asserted-by":"crossref","unstructured":"Fleisher AS, Sun S, Taylor C, Ward CP, Gamst AC, Petersen RC et al.: Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology. 2008; 70(3): 191\u20139.","DOI":"10.1212\/01.wnl.0000287091.57376.65"},{"key":"10.3238\/arztebl.2010.0677_ref34","doi-asserted-by":"crossref","unstructured":"Folstein MF, Folstein SE, McHugh PR: \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3): 189\u201398.","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"10.3238\/arztebl.2010.0677_ref35","doi-asserted-by":"crossref","unstructured":"Milne A, Culverwell A, Guss R, Tuppen J, Whelton R: Screening for dementia in primary care: a review of the use, efficacy and quality of measures. Int Psychogeriatr 2008; 20(5): 911\u2013926.","DOI":"10.1017\/S1041610208007394"},{"key":"10.3238\/arztebl.2010.0677_ref36","unstructured":"Freedman M, Leach L, Kaplan E, et al.: Clock Drawing: A Neuropsychological Analysis. New York: Oxford University Press; 1994."},{"key":"10.3238\/arztebl.2010.0677_ref37","doi-asserted-by":"crossref","unstructured":"Berger G, Fr\u00f6lich L, Weber B, Pantel J: Diagnostic accuracy of the clock drawing test: the relevance of \u201ctime setting\u201c in screening for dementia. J Geriatr Psychiatry Neurol 2008; Dec; 21(4): 250\u201360.","DOI":"10.1177\/0891988708324939"},{"key":"10.3238\/arztebl.2010.0677_ref38","doi-asserted-by":"crossref","unstructured":"Lee H, Swanwick GR, Coen RF, Lawlor BA. Use of the clock drawing task in the diagnosis of mild and very mild Alzheimer\u2019s disease. Int Psychogeriatr 1996; 8: 469\u2013476.","DOI":"10.1017\/S1041610296002827"},{"key":"10.3238\/arztebl.2010.0677_ref39","doi-asserted-by":"crossref","unstructured":"Powlishta KK, von Dras DD, Stanford A, et al.: The Clock Drawing Test is a poor screen for very mild dementia. Neurology 2002; 59: 898\u2013903.","DOI":"10.1212\/WNL.59.6.898"},{"key":"10.3238\/arztebl.2010.0677_ref40","doi-asserted-by":"crossref","unstructured":"Shulman KI, Gold DP. Clock-drawing and dementia in the community: a longitudinal study. Int J Geriatr Psychiatry 1993; 8: 487\u201396.","DOI":"10.1002\/gps.930080606"},{"key":"10.3238\/arztebl.2010.0677_ref41","doi-asserted-by":"crossref","unstructured":"Wilson RS, Arnold SE, Tang X, Bennett DA: Odor identification and decline in different cognitive domains in old age. Neuroepidemiology 2006; 26:61\u201367.","DOI":"10.1159\/000090250"},{"key":"10.3238\/arztebl.2010.0677_ref42","doi-asserted-by":"crossref","unstructured":"Djordjevic J, Jones-Gotman M, De Sousa K, Chertkow H: Olfaction in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2008; 29(5): 693\u20137.","DOI":"10.1016\/j.neurobiolaging.2006.11.014"},{"key":"10.3238\/arztebl.2010.0677_ref43","doi-asserted-by":"crossref","unstructured":"Morris JC, Heyman A, Mohs RC, et al.: The consortium to establish a Registry for Alzheimer`s Disease (CERAD): Clinical and neuropsychological assessment of Alzheimer`s disease. Neurology 1989; 39(9): 1159\u201365.","DOI":"10.1212\/WNL.39.9.1159"},{"key":"10.3238\/arztebl.2010.0677_ref44","doi-asserted-by":"crossref","unstructured":"Misra C, Fan Y, Davatzikos C: Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. Neuroimage 2009; 44(4): 1415\u201322.","DOI":"10.1016\/j.neuroimage.2008.10.031"},{"key":"10.3238\/arztebl.2010.0677_ref45","doi-asserted-by":"crossref","unstructured":"Nordberg A: Amyloid imaging in Alzheimer's disease. Neuropsychologia 2008; 46: 1636\u201341.","DOI":"10.1016\/j.neuropsychologia.2008.03.020"},{"key":"10.3238\/arztebl.2010.0677_ref46","doi-asserted-by":"crossref","unstructured":"Haense C, Buerger K, Kalbe E, et al.: CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease. Eur J Neurol 2008; 15(11): 1155\u201362.","DOI":"10.1111\/j.1468-1331.2008.02274.x"},{"key":"10.3238\/arztebl.2010.0677_ref47","doi-asserted-by":"crossref","unstructured":"Blennow K: Cerebrospinal fluid protein biomarkers for Alzheimer's disease. NeuroRx 2004; 1: 213\u201325.","DOI":"10.1602\/neurorx.1.2.213"},{"key":"10.3238\/arztebl.2010.0677_ref48","doi-asserted-by":"crossref","unstructured":"Lewczuk P, Hornegger J, Zimmermann R, Otto M, Wiltfang J, Kornhuber J: Neurochemical dementia diagnostics: assays in CSF and blood. Eur Arch Psychiatry Clin Neurosci 2008; 258(Suppl 5): 44\u20139.","DOI":"10.1007\/s00406-008-5005-3"},{"key":"10.3238\/arztebl.2010.0677_ref49","doi-asserted-by":"crossref","unstructured":"Engelborghs S, De Vreese K, Van de Casteele T, et al.: Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia. Neurobiol Aging 2008; 29(8): 1143\u201359.","DOI":"10.1016\/j.neurobiolaging.2007.02.016"},{"key":"10.3238\/arztebl.2010.0677_ref50","doi-asserted-by":"crossref","unstructured":"van Oijen M, Hofman A, Soares HD, Koudstaal PJ, Breteler MM: Plasma Abeta (1\u201340) and Abeta (1\u201342) and the risk of dementia: a prospective case-cohort study. Lancet Neurol 2006; 5(8): 655\u201360.","DOI":"10.1016\/S1474-4422(06)70501-4"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2010.0677","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T09:53:09Z","timestamp":1638784389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2010.0677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,1]]},"references-count":50,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2010.0677","relation":{"is-cited-by":[{"id-type":"doi","id":"10.1007\/s00391-016-1174-2","asserted-by":"object"}]},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,1]]}}}